SGLT-2 Inhibitor Use and Erythrocytosis - Dr. Naseema Gangat, Dr. Ayalew Tefferi (Rochester, MN)

แชร์
ฝัง
  • เผยแพร่เมื่อ 7 ธ.ค. 2023
  • Dr. Naseema Gangat and Dr. Ayalew Tefferi discuss the association between SGLT-2 inhibitor use and erythrocytosis, and explain how best to approach patients whose hemoglobin levels increase after SGLT-2 inhibitor initiation.
    Dr. Naseema Gangat and Dr. Ayalew Tefferi are both Professor of medicine and hematologists at the Department of Medicine of the Mayo Clinic Rochester. Their major focus of clinical and academic work are myeloproliferative neoplasms, myelodysplastic syndromes and acute leukemia, where they have written more than 200 joint publications in the last decade.
    The interview was recorded on November 13th, 2023. Moderators: Prof. Dr. Andreas Kronbichler (Innsbruck, Austria) and Prof. Dr. Gunnar Heine (Frankfurt, Germany).
    Articles discussed:
    Sodium-glucose co-transporter-2 inhibitor use and erythrocytosis: assessment of risk and need for referral to haematology.
    Gangat N, Tefferi A.
    Nephrol Dial Transplant 2023
    doi: 10.1093/ndt/gfad171
    Sodium-glucose co-transporter-2 inhibitor treatment in essential thrombocythemia: Impact on hemoglobin/hematocrit levels and outcomes among 11 consecutive patients.
    Gangat N, Reichard K, Tefferi A.
    Am J Hematol 2023
    doi: 10.1002/ajh.27048
    Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial.
    Böhm M, Ezekowitz MD, Connolly SJ, Eikelboom JW, Hohnloser SH, Reilly PA, Schumacher H, Brueckmann M, Schirmer SH, Kratz MT, Yusuf S, Diener HC, Hijazi Z, Wallentin L.
    J Am Coll Cardiol. 2015
    doi: 10.1016/j.jacc.2015.03.577
    Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial.
    Polkinghorne KR, Wetmore JB, Thao LTP, Wolfe R, Woods RL, Ernst ME, Nelson MR, Reid CM, Shah RC, McNeil JJ, Murray AM.
    Am J Kidney Dis. 2022
    doi: 10.1053/j.ajkd.2022.02.019
    Association of Nonsteroidal Anti-inflammatory Drug Prescriptions With Kidney Disease Among Active Young and Middle-aged Adults.
    Nelson DA, Marks ES, Deuster PA, O'Connor FG, Kurina LM.
    JAMA Netw Open. 2019
    doi: 10.1001/jamanetworkopen.2018.7896

ความคิดเห็น •